Blake R. Baer
Research Subjects
Research Interests
Blake R. Baer has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jay D. Raman1 shared publication
- Jay Dilip Raman
Penn State Health Milton S. Hershey Medical Center
1 shared publication - Meghan V. Matheny
College of Medicine, Penn State College of Medicine, 500 University Dr., Hershey, PA 17033, USA
1 shared publication - Natalie Bruno1 shared publication
- Raidizon Mercedes
Department of Urology, Penn State Health, Milton S. Hershey Medical Center, 500 University Dr., Hershey, PA 17033, USA
1 shared publication Stephanie L. Nguyen
1 shared publication
Latest Publications
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (4)
Editorial Comment: Urology Residency Program Directors’ Criteria for Evaluating Applicants
- 1 April 2025
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (4)
Open AccessEditorial Comment: Urology Residency Program Directors’ Criteria for Evaluating Applicants
- Open Access
- 22 February 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (3) , 125
Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy
(1) Background: Upper tract urothelial carcinoma (UTUC) is typically managed through radical nephroureterectomy (RNU) or local ablation (LA). Compared to RNU, LA offers nephron-sparing benefit for select patients but may present increased recurrence risk. This study primarily compares long-term differences between LA and RNU in chronic kidney disease (CKD) progression, estimated glomerular filtration rate (eGFR) decline, all-cause mortality, and need for dialysis. (2) Methods: A retrospective cohort study was conducted using the TriNetX database, examining patients with UTUC treated with RNU (n = 2007) or LA (n = 4172). Propensity score matching balanced both cohorts (n = 1965 per group). Risk ratios and hazard ratios with 95% confidence intervals were calculated over 10 years. (3) Results: At 10 years, LA preserved higher mean eGFR (53.49 vs. 46.72; p < 0.001) and lower mean creatinine (1.56 vs. 1.66; p = 0.017). However, LA held a higher incidence of end-stage renal disease (ESRD) (3.6% vs. 2.2%, p = 0.008) and all-cause mortality (26.7% vs. 23.5%, p = 0.016). There was no significant difference in rates of dialysis (p = 0.79). (4) Conclusions: RNU did not carry an increased risk of ESRD, advanced stages of CKD, need for renal dialysis, or overall mortality compared with LA. LA may delay but not totally prevent renal dysfunction when compared to RNU, and exhibits a more gradual timeline.
- 22 February 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (3) , 125
Open AccessComparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy
(1) Background: Upper tract urothelial carcinoma (UTUC) is typically managed through radical nephroureterectomy (RNU) or local ablation (LA). Compared to RNU, LA offers nephron-sparing benefit for select patients but may present increased recurrence risk. This study primarily compares long-term differences between LA and RNU in chronic kidney disease (CKD) progression, estimated glomerular filtration rate (eGFR) decline, all-cause mortality, and need for dialysis. (2) Methods: A retrospective cohort study was conducted using the TriNetX database, examining patients with UTUC treated with RNU (n = 2007) or LA (n = 4172). Propensity score matching balanced both cohorts (n = 1965 per group). Risk ratios and hazard ratios with 95% confidence intervals were calculated over 10 years. (3) Results: At 10 years, LA preserved higher mean eGFR (53.49 vs. 46.72; p < 0.001) and lower mean creatinine (1.56 vs. 1.66; p = 0.017). However, LA held a higher incidence of end-stage renal disease (ESRD) (3.6% vs. 2.2%, p = 0.008) and all-cause mortality (26.7% vs. 23.5%, p = 0.016). There was no significant difference in rates of dialysis (p = 0.79). (4) Conclusions: RNU did not carry an increased risk of ESRD, advanced stages of CKD, need for renal dialysis, or overall mortality compared with LA. LA may delay but not totally prevent renal dysfunction when compared to RNU, and exhibits a more gradual timeline.